Skip to main navigation menu Skip to main content Skip to site footer
×
English | Español
Editorial
Home
Indexing
Case Report

Case Report: Compassionate application of chlorine dioxide-based solution in a patient with metastatic prostate cancer

By
Manuel Aparicio-Alonso ,
Manuel Aparicio-Alonso

Centro Médico Jurica, Medical Direction and Healthcare Responsibility, Querétaro, México

Search this author on:

PubMed | Google Scholar
Verónica Torres-Solórzano ,
Verónica Torres-Solórzano

Universidad Autónoma de Querétaro, Unit for Basic and Applied Microbiology. Querétaro, México

Search this author on:

PubMed | Google Scholar

Abstract

Chlorine dioxide is a powerful and cost-effective oxidizing agent that has demonstrated anti-cancer activity both in vitro and in vivo. Its proposed mechanism involves the release of free radicals, which disrupt the delicate oxidative balance within cancer cells. In case report, the patient has voluntarily opted for compassionate chlorine dioxide therapy over continuing conventional chemotherapy and immunotherapy due to side effects and uncertain survival outcomes. The concentration of the chlorine dioxide solution was 1/100 times lower than the LOAEL threshold, ensuring that not compromise the patients' health. This is the first follow-up in patient diagnosed with metastatic prostate cancer, who shown tumor reduction at distant sites from the primary tumor with no side effects. This preliminary observation suggests that chlorine dioxide and its free radicals could be potential mediators of an anticancer response. However, it is imperative to emphasize the importance of conducting rigorous clinical trials to validate these initial findings.

How to Cite

1.
Aparicio-Alonso M, Torres-Solórzano V. Case Report: Compassionate application of chlorine dioxide-based solution in a patient with metastatic prostate cancer. Salud, Ciencia y Tecnología [Internet]. 2024 Jan. 3 [cited 2024 Feb. 23];4:699. Available from: https://revista.saludcyt.ar/ojs/index.php/sct/article/view/699

The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.

 

Article metrics

Google scholar: See link

Metrics

Metrics Loading ...

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.